SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Overview Fund Activity
Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

40 hedge funds and large institutions have $7.62M invested in Sio Gene Therapies Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
-1
Holders Change %
-2.44%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
11
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$5K

Top Buyers

1
PCA
Private Capital Advisors
Connecticut
$349K
2
RCMNY
Rubric Capital Management (New York)
New York
$1.96M
3
SW
SVB Wealth
Massachusetts
$26K
4
NM
Newtyn Management
New York
$420K
5
MAM
Meeder Asset Management
Ohio
$16K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
$516K
2
CIA
Cladis Investment Advisory
Montana
$155K
3
Renaissance Technologies
Renaissance Technologies
New York
$101K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$0
5
BCM
Bridgeway Capital Management
Texas
$30K
Name Holding Trade Value Shares
Change 		Shares
Change %
MFG
26
Merit Financial Group
Georgia
$5K – – –
Primecap Management
27
Primecap Management
California
$4K -$282 -1,100 -7%
Morgan Stanley
28
Morgan Stanley
New York
$4K – -1 -0%
UBS Group
29
UBS Group
Switzerland
$1K -$11.3K -51,002 -92%
CAL
30
Capital Advisors Ltd
Ohio
$1K +$345 +687 +53%
WWM
31
Wolff Wiese Magana
California
$1K +$833 +2,000 +500%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
– -$20K -57,187 Closed
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
– -$8K -23,028 Closed
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
– -$7K -20,749 Closed
1
2